Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Retained Earnings (2024 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Retained Earnings for 2 consecutive years, with $66.3 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 287.43% to $66.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.3 million through Dec 2025, up 287.43% year-over-year, with the annual reading at $66.3 million for FY2025, 287.43% up from the prior year.
  • Retained Earnings hit $66.3 million in Q4 2025 for Guardian Pharmacy Services, up from $45.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $66.3 million in Q4 2025 to a low of $5.2 million in Q3 2024.